Regeneron Pharmaceuticals, Inc. (LON: 0R2M)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	59,406	73,329	63,953	48,764	37,347	30,994
Market Cap Growth	18.47%	14.66%	31.15%	30.57%	20.50%	-2.19%
Enterprise Value	46,753	63,131	55,414	42,324	34,998	27,028
Last Close Price	556.79	688.75	591.37	470.42	356.82	283.08
PE Ratio	17.11	23.62	17.76	8.18	14.51	19.40
PS Ratio	8.19	7.12	6.33	4.11	6.00	6.26
PB Ratio	3.87	3.60	3.40	3.52	4.62	3.70
P/TBV Ratio	4.02	3.75	3.54	3.52	4.62	3.70
P/FCF Ratio	32.99	24.10	17.41	10.11	25.45	20.52
P/OCF Ratio	26.71	20.33	15.37	9.32	19.48	16.89
EV/Sales Ratio	4.16	6.13	5.48	3.57	5.62	5.46
EV/EBITDA Ratio	12.47	17.28	12.51	6.17	12.25	14.79
EV/EBIT Ratio	13.95	19.00	13.37	6.37	13.04	16.20
EV/FCF Ratio	18.22	20.75	15.09	8.78	23.85	17.89
Debt / Equity Ratio	0.09	0.11	0.12	0.14	0.24	0.06
Debt / EBITDA Ratio	0.59	0.60	0.52	0.29	0.69	0.29
Debt / FCF Ratio	0.79	0.72	0.63	0.41	1.35	0.36
Asset Turnover	0.40	0.42	0.45	0.75	0.53	0.49
Inventory Turnover	2.44	2.51	2.37	2.74	2.26	2.51
Quick Ratio	4.34	4.82	4.16	2.98	2.86	2.86
Current Ratio	5.28	5.69	5.06	3.56	3.63	3.67
Return on Equity (ROE)	17.17%	16.26%	20.94%	54.21%	31.77%	21.32%
Return on Assets (ROA)	7.41%	8.49%	11.42%	26.39%	14.33%	10.41%
Return on Capital (ROIC)	8.65%	9.76%	13.31%	31.95%	17.95%	12.99%
Earnings Yield	5.85%	4.23%	5.63%	12.23%	6.89%	5.15%
FCF Yield	4.32%	4.15%	5.74%	9.89%	3.93%	4.87%
Buyback Yield / Dilution	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%
Total Shareholder Return	-1.16%	-0.18%	-1.16%	2.52%	-0.44%	0.17%

Source: S&P Capital IQ. Standard template. Financial Sources.